Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 70 for “"FGF23"”.
-
Testing the renal signaling axis for FGF23
FGF23 is the central regulator for phosphate homeostasis. Both FGF23 and phosphate dysregulation are highly related with the progression of chronic kidney disease (CKD), which is a global health problem. In previous studies, FGF23 was found to be produced in bone and targeting the kidneys to …
-
IDENTIFICATION OF A NOVEL SINOATRIAL NODE ACTIVITY REGULATOR: THE PROTEOHORMONE FGF23
FGF23 is a proteohormone mainly produced by osteocytes and osteoblasts whose canonical effect is to regulate the mineral metabolism through the FRS2 α/MAPK pathway activation. This hormone exerts its function mostly in the kidneys where it binds the FGF Receptor (FGFR) complex, which is composed by …
-
Molecular Genetic Analysis of FGF23 Bioactivity in the Bone-Kidney Endocrine Axis
… rickets (ARHR). Fibroblast growth factor-23 (FGF23), identified as the causative gene in ADHR, is produced in bone and plays a central role in kidney phosphate regulation. Increased serum concentrations of FGF23 lead to renal phosphate wasting through down regulation of renal sodium-phosphate …
-
Vitamina D, inflamación y sistema FGF23/KLOTHO : implicaciones en el daño vascular
… bajo el epígrafe Capítulo 2: Expression of FGF23/KLOTHO system in human vascular tissue. International Journal oF Cardiology. Donate-Correa J, Mora-Fernández C, Martínez-Sanz R, Muros-de-Fuentes M, Pérez H, Meneses-Pérez B, Cazaña-Pérez V, Navarro-González JF. International Journal of …
-
Auswirkungen von FGF23 und Klotho auf lokale Mineralisierungsprozesse von Knochenzellen in 3D-Zellkulturen
… wurden zudem osteogen differenziert und mit FGF23 und Klotho stimuliert. Es ergaben sich erste Hinweise auf eine FGF23 / Klotho-abhängige Inhibierung der lokalen Mineralisierung in osteogen differenzierten MLO-A5. Es konnten einige osteogene Marker durch PCR und in den histologischen …
-
Fgf23 Control of Hox Expression and Function and Implications for Chronic Kidney Disease
FGF23 is a hormone that controls metabolic phosphate and vitamin D synthesis in mammals and is overexpressed in chronic kidney disease (CKD). Previous studies have shown that FGF23 initiates transcriptional reprogramming within kidney cells, and therefore epigenetic changes may occur when FGF23 …
-
FGF23-Driven Kidney Adaptations: Unveiling Chromatin Remodeling and Transcriptional Dynamics with Implications for Disease
… anabolic vitamin D 1α- hydroxylase (CYP27B1). FGF23 and 1,25D lower 1,25D by increasing CYP24A1 and suppressing CYP27B1, in contrast to the actions of PTH. Using scRNAseq after FGF23 injections into mice, we found that the E-twenty-six family member ETV1 was stimulated in PT S1-S2 cells in …
-
Non-oxidized PTH - but not oxidized PTH - stimulates FGF23 and increases only moderately in CKD patients
… hormone (PTH) and fibroblast growth factor 23 (FGF23) are regulators of vitamin D metabolism and renal phosphate excretion. In chronic kidney disease (CKD), the concentrations of circulating FGF23 and PTH increase progressively with decreasing renal function. The oxidation of PTH at 2 methionine …
-
Characterization of native FGF23 protein and mutant forms causing autosomal dominant hypophosphatemic rickets and familial tumoral calcinosis
… PHEX, the other for the fibroblast growth factor FGF23. Both proteins are probably involved in a novel common pathway of the regulation of phosphate homeostasis. Missense mutations in FGF23 causing phosphate wasting in patients with ADHR, overexpression of FGF23 in tumors from patients with TIO, …
-
Cardiac-Derived Fibroblast Growth Factor 23 Contributes To Physiologic And Pathologic Cardiac Remodeling
… hormone. Hyperphosphatemia and elevated FGF23 are associated with cardiovascular mortality in CKD. FGF23 can directly target cardiac myocytes via FGF Receptor (FGFR) 4 and induce cardiac hypertrophy and blocking FGFR4 signaling in CKD models reduces cardiac hypertrophy, but not fibrosis. …
-
Τα επίπεδα του αυξητικού παράγοντα των ινοβλαστών 23 (FGF23) και της πρωτεΐνης klotho σε σχέση με την ηλικία και τη νεφρική επαναρρόφηση φωσφόρου στην παιδική ηλικία
… vary with age. Fibroblast Growth Factor 23 (FGF23) is a phosphaturic hormone that plays an important role in phosphate homeostasis. Klotho is the essential co-player of FGF23 that mediates the binding of FGF23 to its receptor. Data for fibroblast growth factor 23 (FGF23) and particularly for …
-
Metabolismo mineral en niños con deficiencia subclínica de vitamina D. Implicaciones del Factor de Crecimiento Fibroblástico 23 (FGF23).
… del factor de crecimiento fibroblástico 23 (FGF23) en las investigaciones relacionadas con la vrtamina D ha despertado el interés por evaluar este parámetro para ampliar la comprensión del metabolismo fosfocálcico en los niños. Esta tesis doctoral pretende arrojar luz sobre la fisiopatología …
-
Relación entre el factor de crecimiento fibroblástico 23 (fgf23) y el fenómeno inflamatorio en la enfermedad vascular aterosclerótica
… inflamación. En este sentido, la aparición del FGF23, además de promover una revisión en los modelos actuales del control del metabolismo mineral. El principal objetivo de esta tesis doctoral es la caracterización de la relación entre FGF23 y la enfermedad vascular aterosclerótica, así como sus …
-
Διερεύνηση της συσχέτισης του αυξητικού παράγοντα των ινοβλαστών-23 και της πρωτεΐνης Κλωθώ με τη μυϊκή και λιπώδη μάζα σε παιδιά με χρόνια νεφρική νόσο
… Disorders of the fibroblast growth factor-23 (FGF23)-Klotho axis constitute early mineral and bone disorders. According to experimental studies, the rise of FGF23 leads to the development of systemic inflammation, anemia and iron deficiency, which affect the progress of nutritional disorders, …
-
Co-Factors In Fgf Signaling
… it has been assumed that endocrine FGFs, such as FGF23, do not bind heparin but instead require klotho, a family of transmembrane proteins, as a co-receptor on specific target cells. FGF23 acts as bone-derived hormone that targets tubular epitheli-al cells in the kidney via FGFR1 and α-klotho to …
-
Testing bone cell models responsive to a soluble form of klotho
Fibroblast growth factor-23 (FGF23) is a hormone produced in bone that acts upon the kidney to control blood phosphate and 1,25-(OH)2 vitamin D concentrations. Chronic kidney disease-mineral bone disorder (CKD-MBD) is a major public health problem, affecting 1 in 8 individuals. These patients can …
-
Investigating the role of fibroblast growth factor 23 in the pathogenesis of uraemic cardiomyopathy
… Circulating hormone fibroblast growth factor 23 (FGF23) is significantly elevated in chronic kidney disease and has previously been associated with cardiac remodelling and mechanoelectrical dysfunction. The work described in this thesis examines the hypothesis that FGF23 is a major player in the …
-
Zusammenhang von FGF 23 mit der hormonellen Regulation des Salz- und Volumenhaushalts bei gesunden Probanden
… somit Volumenmanipulation auf die Expression von FGF23 an gesunden Individuen untersucht. An 20 Probanden zwischen 23 und 49 Jahren (im Mittel 27,3 Jahre) wurde ein Kochsalzbelastungstest, ein Furosemidtest und ein oraler Wasserbelastungstest an jeweils verschiedenen Tagen durchgeführt. Hierbei …
Page 1 of 4